Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Ross Bersot, CFA

Ross Bersot, CFA

President and CEO, Reset Therapeutics

Connect with Ross Bersot, CFA on LinkedIn

About the author: Ross founded Reset Therapeutics in 2008 with Dr. Ronald Evans of the Salk Institute and Drs. Joseph Takahashi and Masashi Yanagisawa from the University of Texas Southwestern Medical Center. Prior to co-founding Reset, Mr. Bersot served as a Managing Director of Bay City Capital, where he focused on investment opportunities in visionary biopharmaceutical and technology companies.  Mr. Bersot received a B.A. in Economics from the University of California, Los Angeles.

Posts by Ross Bersot, CFA

Assessing Our Progress and Looking Ahead

Posted on April 21st, 2017 in The Hive

Like many start-ups, Reset Therapeutics has been driven by big ideas, which we have pursued with passion, commitment and accountability. (more…)

Adding Talent to the Reset Team

Posted on April 7th, 2017 in The Hive

Last year was a significant growth year for Reset Therapeutics, in terms of our work and with our team doubling in size. Reset’s success has been due to a strict focus on our proprietary knowledge of how to modify circadian rhythms in cells, tissues and animals using novel small molecules.  (more…)